Apellis Pharmaceuticals
Earnings Surprise
Analysts estimated APLS earnings of $-0.39 per share this quarter (Q4). APLS's actual earnings were $-0.47 per share.
APLS EPS surprise of -21.01%Analysts estimated APLS earnings of $1.21 per share this quarter (Q3). APLS's actual earnings were $1.67 per share.
APLS EPS surprise of 38.11%Analysts estimated APLS earnings of $-0.48 per share this quarter (Q2). APLS's actual earnings were $-0.33 per share.
APLS EPS surprise of 31.03%Analysts estimated APLS earnings of $-0.37 per share this quarter (Q1). APLS's actual earnings were $-0.74 per share.
APLS EPS surprise of -101.36%Analysts estimated APLS earnings of $-0.39 per share this quarter (Q4). APLS's actual earnings were $-0.29 per share.
APLS EPS surprise of 26.26%Analysts estimated APLS earnings of $-0.31 per share this quarter (Q3). APLS's actual earnings were $-0.46 per share.
APLS EPS surprise of -50.28%Analysts estimated APLS earnings of $-0.33 per share this quarter (Q2). APLS's actual earnings were $-0.28 per share.
APLS EPS surprise of 15.15%Analysts estimated APLS earnings of $-0.48 per share this quarter (Q1). APLS's actual earnings were $-0.42 per share.
APLS EPS surprise of 11.76%Analysts estimated APLS earnings of $-0.70 per share this quarter (Q4). APLS's actual earnings were $-0.73 per share.
APLS EPS surprise of 4.27%